1. |
Ming Y, Shao M, Tian T, et al. Outcome of kidney transplantation between controlled cardiac death and brain death donors:a meta-analysis. Chin Med J (Engl), 2014, 127(15):2829-2836.
|
2. |
Puttarajappa C, Yabes J, Bei L, et al. Cancer risk with alemtuzumab following kidney transplantation. Clin Transplant, 2013, 27(3):E264-E271.
|
3. |
Tanriover B, Mejia A, Weinstein J, et al. Analysis of kidney function and biopsy results in liver failure patients with renal dysfunction:a new look to combined liver kidney allocation in the post-MELD era. Transplantation, 2008, 86(11):1548-1553.
|
4. |
Bahirwani R, Reddy KR. Outcomes after liver transplantation:chronic kidney disease. Liver Transpl, 2009, 15 (Suppl 2):S70-S74.
|
5. |
Aggarwal HK, Jain D, Singla S, et al. Assessment of renal functions in patients of chronic liver disease. Ren Fail, 2015, 4:1-7.
|
6. |
Ginès P, Schrier RW. Renal failure in cirrhosis. N Engl J Med, 2009, 361(13):1279-1290.
|
7. |
Gonwa TA, Mai ML, Melton LB, et al. End-stage renal disease (ESRD) after orthotopic liver transplantation (OLTX) using calcineurin-based immunotherapy:risk of development and treatment. Transplantation, 2001, 72(12):1934-1939.
|
8. |
Locke JE, Warren DS, Singer AL, et al. Declining outcomes in simul-taneous liver-kidney transplantation in the MELD era:ineffective usage of renal allografts. Transplantation, 2008, 85(7):935-942.
|
9. |
O,Leary JG, Orloff SL, Levitsky J, et al. Keeping high MELD liver transplant candidates alive. Liver Transpl, 2015 Sep 3.[Epub ahead of print].
|
10. |
Antunes M, Teixeira A, Fortuna P, et al. Infections after liver trans-plantation:a retrospective, single-center study. Transplant Proc, 2015, 7(4):1019-1024.
|
11. |
Paramesh AS, Roayaie S, Doan Y, et al. Postliver transplant acute renal failure:factors predicting development of end-stage renal disease. Clin Transplant, 2004, 18(1):94-99.
|
12. |
Bémeur C, Butterworth RF. Nutrition in the management of cirrhosis and its neurological complications. J Clin Exp Hepatol, 2014, 4(2):141-150.
|
13. |
Neau-Cransac M, Le Bail B, Guidicelli G, et al. Evolution of serum and intra-graft donor-specific anti-HLA antibodies in a patient with two consecutive livertransplantations. Transpl Immunol, 2015 Aug 28.[Epub ahead of print].
|
14. |
Simpson N, Cho YW, Cicciarelli JC, et al. Comparison of renal allograft outcomes in combined liver-kidney transplantation versus subsequent kidney transplantation in liver transplant recipients:analysis of UNOS database. Transplantation, 2006, 82(10):1298-1303.
|
15. |
Schmitt TM, Kumer SC, Al-Osaimi A, et al. Combined liver-kidney and liver transplantation in patients with renal failure outcomes in the MELD era. Transpl Int, 2009, 22(9):876-883.
|
16. |
Chava SP, Singh B, Zaman MB, et al. Current indications for combined liver and kidney transplantation in adults. Transplant Rev (Orlando), 2009, 23(2):111-119.
|
17. |
Narula N, Bourne M Jr, Bhagra A. Immunosuppression and a serious opportunistic infection:an unfortunate price to pay. BMJ Case Rep, 2015 Jul 7.[Epub ahead of print].
|
18. |
Furman D, Davis MM. New approaches to understanding the immune response to vaccination and infection. Vaccine, 2015 Jul 29.[Epub ahead of print].
|
19. |
Krishnamoorthy TL, Miezynska-Kurtycz J, Hodson J, et al. Long-term corticosteroid use after liver transplantation for autoimmune hepatitis is safe and associated with a lower incidence of recurrent disease. Liver Transpl, 2015 Sep 3.[Epub ahead of print].
|
20. |
Van Wagner LB, Baker T, Ahya SN, et al. Outcomes of patients with hepatitis C undergoing simultaneous liver-kidney transplantation. J Hepatol, 2009, 51(5):874-880.
|
21. |
Ming YZ, Hu J, Luo QZ, et al. Acute antibody-mediated rejection in presence of MICA-DSA and successful renal re-transplant with negative-MICA virtual crossmatch. PloS One, 2015, 10(5):1-10.
|
22. |
Barth RN, Campos L, Kukuruga DL, et al. Antibody-mediated rejection of renal allograft in combined liver-kidney transplant. Clin Transplant, 2010, 24(5):685-690.
|
23. |
Bray RA, Tarsitani C, Gebel HM, et al. Clinical cytometry and progress in HLA antibody detection. Methods Cell Biol, 2011, 103:285-310.
|
24. |
Wu WK, Famure O, Li Y, et al. Delayed graft function and the risk of acute rejection in the modern era of kidney transplantation. Kidney Int, 2015 Jun 24.[Epub ahead of print].
|
25. |
Brieva J, Coleman N, Lacey J, et al. Prediction of death in less than 60 minutes after withdrawal of cardiorespiratory support in potential organ donors after circulatory death. Transplantation, 2014, 98(10):1112-1118.
|
26. |
Morrissey PE, Monaco AP. Donation after circulatory death:current practices, ongoing challenges, and potential improvements. Transplantation, 2014, 97(3):258-264.
|
27. |
Kim JY, Akalin E, Dikman S, et al. The variable pathology of kidney disease after liver transplantation. Transplantation, 2010, 89(2):215-221.
|
28. |
Davis CL, Feng S, Sung R, et al. Simultaneous liver-kidney transplan-tation:evaluation to decision making. Am J Transplant, 2007, 7(7):1702-1709.
|